None listed
Conditions
Interventions
Intervention1: Intranasal dexmedetomidine 1mcg/kg: 1mcg/kg
Intervention2: Intranasal ketamine: 5mg/kg
Control Intervention1: Dexmedetomidine: 0.1 microgram/kg intranasally, once preoperatively, 15 min
Sponsors
Dr Shikha Jain
Eligibility
Inclusion criteria
Inclusion criteria: undergoing elective lower abdominal surgery under caudal block.
Exclusion criteria
Exclusion criteria: History of mental disorders,seizures, Developmental delay, known endocrine disease, recent upper respiratory tract infections, known adverse effects to dexmedetomidine and ketamine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of Emergence agitation after premedication with intranasal dexmedetomidine 1mcg/kg versus intranasal ketamine 5mg/kg calculated by PAEDS scale ( Score of 12 indicating no agitation, 12, indicating agitation)Timepoint: At baseline, 15 minutes,30 minutes, 45 minutes 1 hour, 4 hour, 6 hour, 12 hour, 24 hour | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine and compare mask acceptance scores amongst both groups during induction.Timepoint: At induction of anaesthesia;Incidence of postoperative pain after premedication with intranasal dexmedetomidine 1mcg/kg versus intranasal ketamine 5mg/kg, calculated by FLACCscore groups at extubation and every 15 minute till 1 hr, 4hr, 6hr, 12hr, 24hr.Timepoint: at extubation and every 15 minute till 1 hr, 4hr, 6hr, 12hr, 24hr.;determine and compare hemodynamic parameters and side effects- number of episodes of postoperative nausea and vomiting (PONV), laryngospasm, coughing, salivation, breath holding after intranasal dexmedetomidine and intranasal ketamine Timepoint: Post extubation, every 15 minutes till 1 hour and every 30 minutes the next hour. | — |
Countries
India
Contacts
Public ContactDr Shikha Jain
Aiims bhopal
Outcome results
None listed